Categories: NEWS

Nicola Caronzolo, Sintetica SA, Corporate CEO ,18.11

Nicola Caronzolo, Sintetica SA, Corporate CEO ,18.11

“My Path with Sintetica”

Special Keynote Speaker: Nicola Caronzolo, Corporate CEO, Sintetica SA

When: 18 November 5.45 PM

Where: Executive Center, USI

Nicola Caronzolo, Corporate CEO of Sintetica SA, headquartered in Mendrisio, Switzerland.

SINTETICA SA.

Established in 1921 and headquartered in Mendrisio, Sintetica is a Swiss pharmaceutical company delivering injectable medicines to patients worldwide, through innovative science and excellence in development, production and marketing.

Sintetica has developed a clear innovation strategy following patient needs and new sustainable pharma trends.

For more info, visit the website: https://sintetica.com/

Nicola Caronzolo.

I deeply love this company for which I have worked for 20 years with passion, energy and dedication. I love its nature, its history, the magical mix that we have been able to build, all together, between great professionalism in doing and deep respect in living.

After earning a Bachelor’s degree in Industrial Chemistry at the University of Milan, Nicola Caronzolo specialised in Polymer Science at the Giulio Natta School in Milan. A dual-national, Italian and Swiss, Nicola Caronzolo lives with his family in Lugano, Canton Ticino. After his studies, Mr. Caronzolo worked as an academic researcher at the University of Milan and afterwards for a company that manufactured polymeric support drugs. He joined Sintetica in 2002, when the company was beginning its progressive path of major expansion. He had an extensive career in the Industrial Affairs division and, after several years as Chief Operating Officer, he was appointed CEO of the company in February 2022. In his new role as CEO, Nicola Caronzolo intends to work to consolidate the major strategic directions of marketing Sintetica’s products in the most important global markets.
At the same time, he is committed to further strengthening the innovation sector, one of the hallmarks of this pharmaceutical company known for the quality of its products and its ability to innovate therapies by customising the answers to questions from professionals. What he finds fascinating is that such a growing company faces many challenges. Those challenges are determined by the company itself, and everyone works together to overcome them.

 

Book your place: emba@usi.ch

 

EmbaSt

Recent Posts

Entrepreneurship for Executives – Turn Ideas into Impact

Join the Entrepreneurship module (11 October) and transform ideas into ventures learn customer development and…

1 giorno ago

Last Chances to Discover EMBA: USI EMBA Open Day on 30 September

Final opportunity to discover USI EMBA14 program launching November 2025. Join our last open day…

3 settimane ago

Economics for Executives – Understanding Markets to Make Better Decisions

Experience the USI EMBA Half-Day Class on 13 September, part of our admissions process. Discover…

4 settimane ago

Transform Your Leadership Journey: USI EMBA Open Day on 9 September

Join us for the next USI EMBA Open Day. Explore the next edition starting in…

1 mese ago

The Future of Work: Leading Remote and Hybrid Teams Post-Pandemic

Executive MBA strategies for leading remote and hybrid teams effectively in the post-pandemic workplace.

2 mesi ago

The Executive MBA as Career Accelerator: Strategic Timing for Maximum Impact

Discover how emotional intelligence transforms executive leadership. Learn psychology-based strategies and MBA soft skills to…

2 mesi ago